Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype.
about
Review of renal cell carcinoma and its common subtypes in radiologyUnderstanding and Targeting MET Signaling in Solid Tumors - Are We There Yet?Biomarker development in MET-targeted therapyGenetic and Chromosomal Aberrations and Their Clinical Significance in Renal NeoplasmsRenal cell carcinoma: histological classification and correlation with imaging findingsMet in urological cancersThe metabolic basis of kidney cancerMechanisms of disease: the role of heat-shock protein 90 in genitourinary malignancyPercutaneous radio frequency ablation of small renal tumors: initial resultsThe Nephrologist's Tumor: Basic Biology and Management of Renal Cell Carcinoma.The genetic basis of kidney cancer: a metabolic diseaseTargeted therapies for non-clear renal cell carcinoma.Inherited susceptibility to uterine leiomyomas and renal cell cancerIncidence of end-stage renal disease in the Turkish-Cypriot population of Northern Cyprus: a population based studyKidney pathology: current classification of renal cell carcinoma.Evolving classification of renal cell neoplasia.Repeat partial nephrectomy: surgical, functional and oncological outcomes.Nephron-sparing surgery for multifocal and hereditary renal tumors.Sarcomatoid renal cell carcinoma: a comprehensive review of the biology and current treatment strategies.Unique patterns of allelic imbalance distinguish type 1 from type 2 sporadic papillary renal cell carcinomaInherited forms of renal cell carcinoma.Renal cancer: oxygen meets metabolismThe genetic basis of cancer of kidney cancer: implications for gene-specific clinical management.Molecular pathogenetics of renal cancer.Role of carbonic anhydrases in the progression of renal cell carcinoma subtypes: proposal of a unified hypothesis.New strategies in renal cell carcinoma: targeting the genetic and metabolic basis of disease.Current understanding of the molecular mechanisms of kidney cancer: a primer for urologists.Genetic basis of kidney cancer: a model for developing molecular-targeted therapies.Initial clinical sensitivity and acquired resistance to MET inhibition in MET-mutated papillary renal cell carcinomaTyrosine kinase inhibitors and anti-angiogenic therapies in kidney cancer.Oncocytic papillary renal cell carcinoma: a clinicopathological study emphasizing distinct morphology, extended immunohistochemical profile and cytogenetic features.MicroRNA profiles classify papillary renal cell carcinoma subtypes.Hereditary kidney cancer: unique opportunity for disease-based therapy.Recent developments in the treatment of renal cell carcinoma.Targeting the Met signaling pathway in renal cancer.Hereditary kidney cancer syndromes.Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management.Meta-analysis of gene expression and integrin-associated signaling pathways in papillary renal cell carcinoma subtypes.Epidermal growth factor receptor mutation and diverse tumors: case report and concise literature review.Understanding the molecular genetics of renal cell neoplasia: implications for diagnosis, prognosis and therapy.
P2860
Q26744297-4D91688F-BB0B-42DD-AD31-CA223698A13BQ26748581-8638E5F4-0F7C-4CFD-A57F-A1E5198079B0Q26751332-B535C725-F727-4537-9A17-401574EB68F2Q26785930-5CD9A314-160E-473C-92D6-5D7184540F2DQ26799781-39F39A6A-4629-4861-BD00-933C6FE4C31EQ26864988-F48D572D-399A-4AC8-B464-E60EF1F30981Q27023273-FB8DBA38-4A0E-4CBC-B590-A72A79C31B4EQ28272747-5E0D686A-F326-49D1-9839-315AD1E00FF7Q28366424-F58BBD88-ADB2-47B4-AB67-5F6BC769F694Q30277177-A6B64F9D-AFD7-4C9E-930B-C74ABC5E9927Q34087148-66B43630-6B27-47BC-A864-BBAA5A45C411Q34412479-541C93F8-91C3-4A0C-8BB1-C37B8075B654Q34514090-0E38089A-5B8A-4D8B-80F4-9535E7C01F36Q34563036-CCF4EA50-9F5C-4FD1-8157-A73C24647403Q34707226-75B77CA8-B6E4-4E8F-B10B-C2C928658460Q34734172-DADCC23C-6268-479B-9679-2DFAA933F3B3Q35214956-29191195-6A02-4E84-A781-BDBF89C4B827Q35638401-406B8888-9D88-4F3A-860D-2995ACCC3E52Q35705266-593D3B01-A175-454D-81D4-E5F7BCCCDD18Q35789042-8D83D894-B2FC-46EE-98C3-2620C17CF0D8Q35851661-B265A878-5CA7-4D42-B665-554881B56A1CQ35907065-00FA9B72-D562-49FE-AC86-E94626EA8089Q36048466-61F3A224-7B47-4A94-A78A-9603F4023DB8Q36492055-C6007D04-334B-41BD-A4FD-04AD214E4316Q36680692-13A693E9-FBDA-4B29-A7C6-BDA35E6EFB67Q36696610-126B9173-C6BA-4291-B929-4CAF6B11CFB3Q36710400-DF5878AD-CAA3-4AD5-9A16-6BA1A858CABBQ36794767-4B272106-1539-4B83-BE97-4BF64A93C3B2Q36868642-86423F1A-3028-4873-B22B-2EC341448841Q36915973-A6EF9016-506B-4D51-AAE6-061FF4717166Q36956224-B761415D-91C1-4608-B2D8-1097792E09D4Q37081880-260E9A01-A246-4B6E-9C9D-7E763789A59EQ37287088-9F0305C8-FDE9-4C47-A31C-EB8330C63A5BQ37300942-CE5A9449-65D3-41F1-9352-155AEF04E639Q37331862-BB406E8C-9D67-46CC-BD0A-32351616775FQ37412363-229FE915-4726-4EB6-994F-4463821271F7Q37549886-75B1DED1-2EE4-4F56-8C21-8D1AA58E179BQ37708931-65EAEF56-A160-4BC1-AE6A-7E07B3A26D6DQ37719929-0E39DC23-C4A8-4C57-9DC8-DEDFF0A39B87Q37765586-0F7B09D9-EA71-40FB-8A3D-316DA6420755
P2860
Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Hereditary and sporadic papill ...... tinct morphological phenotype.
@ast
Hereditary and sporadic papill ...... tinct morphological phenotype.
@en
type
label
Hereditary and sporadic papill ...... tinct morphological phenotype.
@ast
Hereditary and sporadic papill ...... tinct morphological phenotype.
@en
prefLabel
Hereditary and sporadic papill ...... tinct morphological phenotype.
@ast
Hereditary and sporadic papill ...... tinct morphological phenotype.
@en
P2093
P2860
P1476
Hereditary and sporadic papill ...... tinct morphological phenotype.
@en
P2093
I A Lubensky
M M Walther
N Zambrano
W M Linehan
P2860
P304
P356
10.1016/S0002-9440(10)65147-4
P407
P577
1999-08-01T00:00:00Z